Treatment of CRTH2-mediated diseases and conditions
US8163931B2 · kind B2 · utility
6Cited by
16References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2008 |
| Grant date | Apr 24, 2012 |
| Priority date | — |
| Expiry date | Jun 29, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides indole derivatives that antagonize prostaglandin D2, and that can be used to treat inflammatory diseases mediated by prostaglandin D2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.